Moramide intermediate
From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
| Clinical data | |
|---|---|
| Trade names | β-Methyl-α,α-diphenyl-4-morpholinebutanoic acid |
| Other names | 4-Morpholinebutanoic acid, β-methyl-α,α-diphenyl-, moramide intermediate |
| Routes of administration | N/A |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C21H25NO3 |
| Molar mass | 339.435 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Moramide intermediate (β-Methyl-α,α-diphenyl-4-morpholinebutanoic acid, on INCB Yellow List as 2-methyl-3-morpholino-1,1-diphenylpropane carboxylic acid) is a moramide precursor scheduled by UN Single Convention on Narcotic Drugs.
In the United States, moramide intermediate is designated as a Schedule II controlled substance,[2] and has an ACSCN of 9802. The 2014 annual manufacturing quota was nil.[3]
In Australia, moramide intermediate is listed as a Schedule 9 (Prohibited Substance) [4]
See also
[edit ]- Moramide
- Methadone intermediate
- Pethidine intermediate A
- Pethidine intermediate B (norpethidine)
- Pethidine intermediate C (pethidinic acid)
References
[edit ]- ^ Anvisa (2023年03月31日). "RDC No 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023年04月04日). Archived from the original on 2023年08月03日. Retrieved 2023年08月16日.
- ^ Controlled Substances - by DEA Drug Code Number
- ^ "DEA Diversion Control Division".
- ^ "Therapeutic Goods (Poisons Standard—February 2024) Instrument 2024". Federal Register of Legislation. 23 January 2024. Retrieved 18 June 2024.